Fredericamycin derivatives

US7459462B2 · kind B2 · utility

Assignee

• Biofrontera Discovery GmbH · DE

Inventors

• Werner Simon · Seeheim-Jugenheim, DE
• Ulrich Abel · Schifferstadt, DE

Key dates

• Filing date: Mar 28, 2003
• Grant date: Dec 2, 2008
• Expiry date: Mar 2, 2024

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D413/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The invention relates to novel fredericamycin derivatives, to medicaments containing these derivatives or salts thereof, and to the use of fredericamycin derivatives for treating diseases, particularly tumor diseases.